|
ISIN No
|
INE485C01029
|
BSE Code / NSE Code
|
524164 / IOLCP
|
Book Value (Rs.)
|
63.47
|
Face Value
|
2.00
|
|
Bookclosure
|
17/02/2026
|
52Week High
|
219
|
EPS
|
4.69
|
P/E
|
44.66
|
|
Market Cap.
|
6146.17 Cr.
|
52Week Low
|
67
|
P/BV / Div Yield (%)
|
3.30 / 0.48
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
The company history sections lists out major chronological events that happened to the company.
| 2003
-Shareholders approved the delisting of equity shares of the company from Ludhiana and Delhi Stock Exchanges.
-Increase in Authorised Capital of the Company from Rs 150 million to Rs 200 million.
2004
-Industrial Organics Ltd has informed that after the resignation of Shri N C Gupta, Chairman cum Director, Shri Varinder Gupta, Managing Director of the Company has been appointed as Chairman of the Board of Directors.
2007
- Company name has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Ltd.
2008
-IOL Chemicals & Pharmaceuticals has been granted a Certificate of Registration by BSI Management System, for Quality Management System ISO 9001:2000 and for Environment Management System / 14001:2004
-IOL Chemicals has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan.
-IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources.
2009
-Sh. Parminder Singh Cheema has been appointed as Nominee Director on the Board of the Company
-IOL Chemicals announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively,
-IOL Chemicals has received DMF acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, the drug regulatory body of Canada to enable it to export ibuprofen in that country.
-IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2009 (second rank in Drugs & Pharmaceuticals Sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources of the country.
-IOL Chemicals and Pharmaceuticals felicitated by PEDA for Energy Conservation
2010
-IOL Chemicals has obtained a Certificate of Suitability for its manufacturing facilities for Ibuprofen from European Directorate for the Quality of Medicines and HealthCare.
-IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010
2011
-IOL Chemicals's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi.
-IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011
2012
-IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012
2013
-IOL Chemicals & Pharmaceuticals won "National Energy Conservation award (Drug and Pharma sector)2013"
2014
-IOL Chemicals & Pharmaceuticals Ltd. won "National Energy Conservation Award 2014".
2015
-IOLCP to launch API business in US market
-IOL Chemicals completes De-bottlenecking project
2020
-IOL Chemicals and Pharmaceuticals Ltd got EUGMP Certification from National Institute of Pharmacy and Nutrition
2021
- IOL Chemicals and Ph Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen
2024
-Indian Chemical Council (ICC) awarded Responsible Care Logo to the Company.
-IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'National Medical Products Administration (NMPA), China approves Fenofibrate manufactured by the Company.
2025 -IOL Awarded EcoVadis Silver Medal - Ranks Among the Top 15% companies globally. -The Company has splits its face value from Rs. 10/- to Rs. 2/-.
|